These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11060721)

  • 1. Therapeutic potential of complement inhibitors in myocardial ischaemia.
    Lucchesi BR; Tanhehco EJ
    Expert Opin Investig Drugs; 2000 May; 9(5):975-91. PubMed ID: 11060721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement.
    Monsinjon T; Richard V; Fontaine M
    Fundam Clin Pharmacol; 2001 Oct; 15(5):293-306. PubMed ID: 11903498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation and inhibition in myocardial ischemia and reperfusion injury.
    Homeister JW; Lucchesi BR
    Annu Rev Pharmacol Toxicol; 1994; 34():17-40. PubMed ID: 8042849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation in heart diseases. Role of oxidants.
    Chakraborti T; Mandal A; Mandal M; Das S; Chakraborti S
    Cell Signal; 2000 Oct; 12(9-10):607-17. PubMed ID: 11080612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of complement activation in the isolated heart. Role of the terminal complement components.
    Homeister JW; Satoh P; Lucchesi BR
    Circ Res; 1992 Aug; 71(2):303-19. PubMed ID: 1628389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy.
    Vakeva AP; Agah A; Rollins SA; Matis LA; Li L; Stahl GL
    Circulation; 1998 Jun; 97(22):2259-67. PubMed ID: 9631876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement, neutrophils and free radicals: mediators of reperfusion injury.
    Lucchesi BR
    Arzneimittelforschung; 1994 Mar; 44(3A):420-32. PubMed ID: 8185717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium.
    Väkevä A; Morgan BP; Tikkanen I; Helin K; Laurila P; Meri S
    Am J Pathol; 1994 Jun; 144(6):1357-68. PubMed ID: 7515561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complement system in myocardial ischaemia/reperfusion injury.
    Kilgore KS; Friedrichs GS; Homeister JW; Lucchesi BR
    Cardiovasc Res; 1994 Apr; 28(4):437-44. PubMed ID: 8181029
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlling the complement system in inflammation.
    Kirschfink M
    Immunopharmacology; 1997 Dec; 38(1-2):51-62. PubMed ID: 9476114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.
    Amsterdam EA; Stahl GL; Pan HL; Rendig SV; Fletcher MP; Longhurst JC
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H448-57. PubMed ID: 7840295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement inhibitors in myocardial ischemia/reperfusion injury.
    Lucchesi BR; Kilgore KS
    Immunopharmacology; 1997 Dec; 38(1-2):27-42. PubMed ID: 9476112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical applications of recombinant complement inhibitors].
    Lipiński D; Pławski A; Juzwa W; Zeyland J; Słomski R
    Pol Merkur Lekarski; 2004 Jun; 16(96):571-5. PubMed ID: 15510900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future use of complement inhibitors for the treatment of neurological diseases.
    McGeer EG; McGeer PL
    Drugs; 1998 Jun; 55(6):739-46. PubMed ID: 9617589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome analysis of myocardial tissue following ischemia and reperfusion--effects of complement inhibition.
    Buerke M; Schwertz H; Längin T; Buerke U; Prondzinsky R; Platsch H; Richert J; Bomm S; Schmidt M; Hillen H; Lindemann S; Blaschke G; Müller-Werdan U; Werdan K
    Biochim Biophys Acta; 2006 Oct; 1764(10):1536-45. PubMed ID: 17045855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The complement system: an old story or target of new therapeutic approaches?].
    Heller A; Koch T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Apr; 35(4):207-13. PubMed ID: 10830072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic inhibition of the complement system. Y2K update.
    Asghar SS; Pasch MC
    Front Biosci; 2000 Sep; 5():E63-81. PubMed ID: 10966868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
    Thrane AS; Skehan JD; Thrane PS
    Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition.
    Duehrkop C; Rieben R
    Biochem Pharmacol; 2014 Mar; 88(1):12-22. PubMed ID: 24384116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of the complement system currently in development for cardiovascular disease.
    Pugsley MK; Abramova M; Cole T; Yang X; Ammons WS
    Cardiovasc Toxicol; 2003; 3(1):43-70. PubMed ID: 12668890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.